Active surveillance for patients with Low-risk Prostate Cancer: How Does PSA Doubling time Affect the Risk of Histopathological Progression at Re-biopsy?

Frderik Birkebæk Thomsen; Martin Andreas Røder; Helle Hvarness; Peter Iversen; Klaus Brasso

doi:10.1016/S0090-4295(12)00879-5

Active surveillance for patients with Low-risk Prostate Cancer: How Does PSA Doubling time Affect the Risk of Histopathological Progression at Re-biopsy?

Frderik Birkebæk Thomsen, Martin Andreas Røder, Helle Hvarness, Peter Iversen, Klaus Brasso

Original language	English
Journal	Urology
Volume	80
Issue number	3
Pages (from-to)	1-135
ISSN	0090-4295
DOIs	https://doi.org/10.1016/S0090-4295(12)00879-5
Publication status	Published - Sept 2012
Event	32nd Congress of the Société Internationale d'Urologie - Fokuoka, Japan Duration: 30 Sept 2012 → 4 Oct 2012

Conference

Conference	32nd Congress of the Société Internationale d'Urologie
Country/Territory	Japan
City	Fokuoka
Period	30/09/2012 → 04/10/2012

Access to Document

10.1016/S0090-4295(12)00879-5

Cite this

@article{ab0ef15928984eb6aaef20c0dd1e20b4,

title = "Active surveillance for patients with Low-risk Prostate Cancer: How Does PSA Doubling time Affect the Risk of Histopathological Progression at Re-biopsy?",

author = "Thomsen, {Frderik Birkeb{\ae}k} and R{\o}der, {Martin Andreas} and Helle Hvarness and Peter Iversen and Klaus Brasso",

year = "2012",

month = sep,

doi = "10.1016/S0090-4295(12)00879-5",

language = "English",

volume = "80",

pages = "1--135",

journal = "Urology",

issn = "0090-4295",

publisher = "Excerpta Medica, Inc",

number = "3",

note = "32nd Congress of the Soci{\'e}t{\'e} Internationale d'Urologie ; Conference date: 30-09-2012 Through 04-10-2012",